Myocardial Perfusion and Ventricular Function Assessed by SPECT and Gated-SPECT in End-Stage Renal Disease Patients before and after Renal Transplant

Archives of Medical Research

Volumn 38, Issue 2, 2007, Pages 227-233

  Bialostozky, David ^a   Leyva, Mayela ^a   Villarreal, Teresa ^a   Casanova, J Miguel ^b   Pérez Grovas, Héctor ^a   Lemus, Patricia ^a   Jiménez, Guadalupe ^a   Vallejo, Enrique ^a   Jiménez Angeles, Luis ^a   Herrera, Jaime ^a   Altamirano, Javier ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Gated SPECT; Left ventricular function; Myocardial perfusion; Renal transplantation; SPECT; Uremic cardiomyopathy

Indexed keywords

ADOLESCENT; ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMEGALY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; DYSKINESIA; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE PERFUSION; HEART VENTRICLE FUNCTION; HEART VENTRICLE WALL MOTION; HUMAN; HYPOKINESIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTOLIC DYSFUNCTION; TREATMENT INDICATION; TREATMENT OUTCOME; UREMIC CARDIOMYOPATHY;

ADOLESCENT; ADULT; CORONARY CIRCULATION; FEMALE; GATED BLOOD-POOL IMAGING; HEART DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 33846136981     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2006.09.017     Document Type: Article

References (48)

1. Munter P., He J., Astor B.C., Folsom A.R., and Cjoresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol 16 (2005) 529-538
2. United States Renal Data System. Causes of Death. Annual data report (1995), National Institute of Diabetes and Digestive and Kidney Diseases. National Institutes of Health, Bethesda, MD
3. European Transplant and Dialysis Association. Report on management of renal failure in Europe XIII, 1991. Nephron Dialysis Transplant 10 suppl 5 (1995) 12
4. Muntner P., He J., Ham L., Loria C., and Whelton P.K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13 (2002) 745-753
5. Lai K.N., Barnden L., and Mathew T.H. Effect on renal transplant on left ventricular function in hemodialysis patients. Clin Nephrol 18 (1982) 74-78
6. Colan S.D., Sanders S.P., Ingelfinger J.R., and Harmon W. Left ventricular mechanics and contractile state in children and young adults with end stage renal disease: effects of dialysis and renal transplant. J Am Coll Cardiol 10 (1987) 1085-1094
7. Fleming S.J., Caplin J.L., Banim S.O., and Baker L.R.I. Improved cardiac function after renal transplant. Postgrad Med J 61 (1985) 525-528
8. Burt R.K., Gupta-Burt S., Suki W., Bárcenas C.G., Ferguson J.J., and Van Buren C.T. Reversal of left ventricular dysfunction after renal transplant. Ann Int Med 111 (1989) 635-640
9. Abouma G.M., Kumar M.S., Silvia O.S., Samhan M., Cheriyan G., al-Abdulla I., et al. Reversal of myocardial dysfunction following renal transplant. Transplant Proc 25 (1993) 1034-1035
10. Himelman R.B., Landzberg J.S., Simonson J.S., Ahmed W., Bouchard A., Merz R., et al. Cardiac consequences of renal transplant. Changes in left ventricular morphology and function. J Am Coll Cardiol 12 (1988) 915-923
11. Drueke T., Le Pailleur C., Melhac B., Koutoudis C., Zingraff J., DiMatteo J., et al. Congestive cardiomyopathy in uremic patients on long-term hemodialysis. Br Med J 1 (1977) 350-353
12. Parfrey P.S., Harnett J.D., Foley R.N., Kent G.M., Murray D.C., Barre P.E., et al. Impact of renal transplant on uremic cardiomyopathy. Transplant 60 (1995) 908-914
13. Nagle F.J., Balke B., and Naughton J.P. Gradational step test for assessing work capacity. J Appl Physiol 4 (1965) 745-748
14. McInnis K.J., and Balady G.J. Comparison of submaximal exercise responses using the Bruce vs modified Bruce protocols. Med Sci Sports Exer 1 (1994) 103-107
15. Leppo J.A. Dypiridamol-thallium imaging: the lazy man's stress test. J Nucl Med 30 (1989) 281-287
16. Germano G., Kiat H., Kavanagh P.B., Moriel M., Mazzanti M., Su H.-T., et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36 (1995) 2138-2147
17. Taillefer R. Technetium-99m sestamibi myocardial imaging: same-day rest-stress studies and dipyridamole. Am J Cardiol 66 (1990) 80E-84E
18. Cerqueira D.M., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., et al. Standard myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol 9 (2002) 240-245
19. Arrighi J.A., and Soufer R. Reverse redistribution: is it clinically relevant or a washout?. J Nucl Cardiol 5 (1998) 195-201
20. McGonigle R.J.S., Fowler M.B., Timmis A.B., Weston M.J., and Parsons V. Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone. Nephron 36 (1984) 94-100
21. Roig E., Bertriu A., Castañer A., Magriña J., Sanz G., and Navarro-López F. Disabling angina pectoris with normal coronaries in patients undergoing long-term hemodialysis. Am J Med 71 (1981) 431-434
22. Pastan S.O., and Mitch W.E. The heart and kidney disease. In: Schlant R.C., and Alexander R.W. (Eds). Hurst's The Heart, Arteries and Veins. 9th ed. (1998), McGraw-Hill, New York 2415-2423
23. Rostand S.G., and Rutsky E.A. Ischemic heart disease in chronic renal failure: management considerations. Semin Dialysis 2 (1989) 98-101
24. Harnett J.D., and Parfrey P.S. Left ventricular dysfunction in dialysis subjects. In: Henrich W. (Ed). Principles and Practice of Dialysis (1994), Williams & Wilkins, Baltimore 170-180
25. Amann K., Wiest G., Zimmer G., Gretz N., Ritz E., and Mall G. Reduced capillary density in the myocardium of uremic rats. A stereological study. Kidney Int 42 (1992) 1079-1085
26. Raumauseck M., Ritz E., Mall G., Mehls O., and Katus H. Myocardial hypertrophy in rats with renal insufficiency. Kidney Int 28 (1985) 775-787
27. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575
28. Middleton R.J., Parfrey P.S., and Foley R.N. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12 (2001) 1079-1084
29. Zhang Y.-B., Smogorzewski M., Ni Z., and Nassry S.G. Altered cytosolic calcium homeostasis in rat cardiac myocytes in chronic renal failure. Kidney Int 45 (1994) 113-119
30. Amman K., Ritz E., Wiest G., Klaus G., and Mall G. A role of the parathyroid hormone for activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4 (1994) 1814-1819
31. Smogorzewski M., and Massry S.G. Uremic cardiomyopathy: role of parathyroid hormone. Kidney Int 52 (1997) S12-S14
32. Massry S.G., and Smogorzewski M. Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia. Semin Nephrol 14 (1994) 219-231
33. Bogin E., Massry S.G., and Harary I. Effect of parathyroid hormone in heart cells. J Clin Invest 67 (1981) 1215-1227
34. Amann K., Gassmann P., Buzello M., Orth S.R., Tornig J., Gross M.L., et al. Effects of ACE inhibition and bradykinin antagonists on cardiovascular changes in uremic rats. Kidney Int 58 (2000) 153-161
35. Raggi P. Detection and quantification of cardiovascular calcifications with electron beam tomography to estimate risk in hemodialysis patients. Clin Nephrol 54 (2000) 325-333
36. Goodman W.G., Goldin J., Kuizon B.D., Yoon C., Gales B., Sider D., et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
37. Guerin A.P., London G.M., Marchais S.J., and Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15 (2000) 1014-1021
38. Ribeiro S., Ramos A., Brandao A., Rebelo J.R., Guerra A., Resina C., et al. Cardiac valve calcification in hemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant 13 (1998) 2037-2040
39. Maher E.R., Pazianas M., and Curtis J.R. Calcific aortic stenosis. A complication of chronic uremia. Nephron 47 (1987) 119-122
40. Kelm M., Schafer S., Mingers S., Heydthausen M., Vogt M., Motz W., et al. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens 14 (1996) 1357-1364
41. Remuzzi G. Sympathetic overactivity in hypertensive patients with chronic renal disease. N Engl J Med 340 (1999) 1360-1361
42. Bernardi D., Bernini L., Cini G., Ghione S., and Bonechi I. Asymmetric septal hypertrophy and sympathetic overactivity in normotensive hemodialyzed patients. Am Heart J 109 (1985) 539-545
43. Lai K.N., Ng J., Whitford J., Buttfield J., Fassett R.G., and Mathew T.H. Left ventricular function in uremia. Echocardiographic and radionucleide assessment in patients on maintenance hemodialysis. Clin Nephrol 23 (1985) 125-133
44. Burke J.F., Franco G.C., Moore L.L., Cho Y.S., and Lasker N. Accelerated atherosclerosis in chronic dialysis patients. Another look. Nephron 21 (1978) 181-187
45. Lewis B.S., Milne F.J., and Goldberg B. Left ventricular function in chronic renal failure. Br Heart J 38 (1976) 1229-1239
46. Hutting J., Kramer W., Schutterie G., and Wizemann V. Analysis of left ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study. Nephron 49 (1988) 284-290
47. Stepp D.W., Nishikawa Y., and Chilian W.M. Regulation of shear stress in the canine coronary microcirculation. Circulation 100 (1999) 1555-1561
48. Sadoshima J., Zhihua Q., Morgan J.P., and Izumo S. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca2+ dependent signaling. Circ Res 76 (1995) 1-15